| scholarly article | Q13442814 |
| P50 | author | Melitta Schachner | Q1622212 |
| P2093 | author name string | Jian Chen | |
| Alexandros A Lavdas | |||
| Rebecca Matsas | |||
| Florentia Papastefanaki | |||
| Dimitra Thomaidou | |||
| P433 | issue | Pt 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Schwann cell | Q465621 |
| P304 | page(s) | 2159-2174 | |
| P577 | publication date | 2007-07-11 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Grafts of Schwann cells engineered to express PSA-NCAM promote functional recovery after spinal cord injury | |
| P478 | volume | 130 |
| Q35127777 | A systematic review of cellular transplantation therapies for spinal cord injury |
| Q37967675 | Advanced cell therapies with and without scaffolds. |
| Q37526111 | Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury. |
| Q37476168 | Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord |
| Q35186443 | Comparison of polymer scaffolds in rat spinal cord: a step toward quantitative assessment of combinatorial approaches to spinal cord repair |
| Q37281196 | Control of demyelination for recovery of spinal cord injury |
| Q38809907 | Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials? |
| Q36155149 | Down-regulation of the axonal polysialic acid-neural cell adhesion molecule expression coincides with the onset of myelination in the human fetal forebrain |
| Q30493156 | Ectopic expression of polysialylated neural cell adhesion molecule in adult macaque Schwann cells promotes their migration and remyelination potential in the central nervous system |
| Q36317365 | Effect of hyperbaric oxygen on MMP9/2 expression and motor function in rats with spinal cord injury |
| Q36294720 | Enzymatic engineering of polysialic acid on cells in vitro and in vivo using a purified bacterial polysialyltransferase |
| Q35295364 | Extensive cell migration, axon regeneration, and improved function with polysialic acid-modified Schwann cells after spinal cord injury |
| Q38366783 | From demyelination to remyelination: the road toward therapies for spinal cord injury |
| Q57807765 | Functional Role of the Interaction between Polysialic Acid and Extracellular Histone H1 |
| Q54654209 | Functional and Histological Improvement of the Injured Spinal Cord Following Transplantation of Schwann Cells Transfected With NRG1 Gene |
| Q26825131 | Gene delivery strategies to promote spinal cord repair |
| Q37948144 | Gene transfer mediated by stem cell grafts to treat CNS injury |
| Q35039266 | Grueneberg ganglion olfactory subsystem employs a cGMP signaling pathway |
| Q36222821 | Hyperbaric oxygen therapy combined with Schwann cell transplantation promotes spinal cord injury recovery. |
| Q35046949 | Hyperbaric oxygen therapy improves local microenvironment after spinal cord injury |
| Q53935058 | Impact of neural cell adhesion molecule deletion on regeneration after mouse spinal cord injury. |
| Q39681880 | Interactions between Schwann and olfactory ensheathing cells with a starch/polycaprolactone scaffold aimed at spinal cord injury repair |
| Q36756735 | Intraspinal Delivery of Polyethylene Glycol-coated Gold Nanoparticles Promotes Functional Recovery After Spinal Cord Injury. |
| Q39834568 | Lipopolysaccharide induced upregulation of beta-1,4-galactosyltransferase-I in Schwann cell |
| Q89537143 | Magnetic Field Promotes Migration of Schwann Cells with Chondroitinase ABC (ChABC)-Loaded Superparamagnetic Nanoparticles Across Astrocyte Boundary in vitro |
| Q37509976 | Manipulation of Schwann cell migration across the astrocyte boundary by polysialyltransferase-loaded superparamagnetic nanoparticles under magnetic field |
| Q35046951 | Mild hypothermia combined with a scaffold of NgR-silenced neural stem cells/Schwann cells to treat spinal cord injury |
| Q49087870 | Neural stem/progenitor cells differentiate into oligodendrocytes, reduce inflammation, and ameliorate learning deficits after transplantation in a mouse model of traumatic brain injury. |
| Q46074947 | Nonyloxytryptamine mimics polysialic acid and modulates neuronal and glial functions in cell culture |
| Q43534702 | Olfactory ensheathing cells, but not Schwann cells, proliferate and migrate extensively within moderately X-irradiated juvenile rat brain |
| Q37517222 | Oligodendrocyte development and the onset of myelination in the human fetal brain |
| Q42072450 | Overexpression of polysialylated neural cell adhesion molecule improves the migration capacity of induced pluripotent stem cell-derived oligodendrocyte precursors |
| Q28071648 | Peripheral Nerve Injury: Stem Cell Therapy and Peripheral Nerve Transfer |
| Q52626491 | Peripheral nerve repair with cultured schwann cells: getting closer to the clinics. |
| Q33730423 | Polysialic acid glycomimetic promotes functional recovery and plasticity after spinal cord injury in mice |
| Q37024530 | Polysialic acid in the plasticity of the developing and adult vertebrate nervous system |
| Q38265379 | Polysialic acid: biosynthesis, novel functions and applications |
| Q26996685 | Potential role of stem cells in severe spinal cord injury: current perspectives and clinical data |
| Q83292612 | Promoting survival, migration, and integration of transplanted Schwann cells by over-expressing polysialic acid |
| Q64981683 | Regeneration of Spinal Cord Connectivity Through Stem Cell Transplantation and Biomaterial Scaffolds. |
| Q38026986 | Regenerative medicine for the treatment of spinal cord injury: more than just promises? |
| Q46148664 | Roles of Polysialic Acid in Migration and Differentiation of Neural Stem Cells |
| Q33794697 | Schwann Cell Precursors from Human Pluripotent Stem Cells as a Potential Therapeutic Target for Myelin Repair |
| Q53476981 | Schwann cell precursors transplanted into the injured spinal cord multiply, integrate and are permissive for axon growth. |
| Q38254430 | Schwann cell transplantation and descending propriospinal regeneration after spinal cord injury. |
| Q89571234 | Schwann cells: Rescuers of central demyelination |
| Q26995291 | Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration |
| Q52709495 | Soluble forms of the cell adhesion molecule L1 produced by insect and baculovirus‐transduced mammalian cells enhance Schwann cell motility |
| Q38271886 | Stem cell-based approaches to improve nerve regeneration: potential implications for reconstructive transplantation? |
| Q37724310 | Superparamagnetic Iron Oxide Nanoparticle-Mediated Forces Enhance the Migration of Schwann Cells Across the Astrocyte-Schwann Cell Boundary In vitro |
| Q34997967 | Tegaserod mimics the neurostimulatory glycan polysialic acid and promotes nervous system repair |
| Q37152815 | The chemical neurobiology of carbohydrates |
| Q37929437 | The injured and regenerating nervous system: immunoglobulin superfamily members as key players |
| Q37024121 | The polysialic acid mimetics 5-nonyloxytryptamine and vinorelbine facilitate nervous system repair |
| Q54035553 | Towards personalized cell-replacement therapies for brain repair. |
| Q47847883 | WITHDRAWN: Use of PSA-NCAM in Repair of the Central Nervous System |
| Q89516626 | Xenogeneic Neu5Gc and self-glycan Neu5Ac epitopes are potential immune targets in MS |
Search more.